James W Welsh

Inhibition of MER proto-oncogene tyrosine kinase by an antisense oligonucleotide enhances treatment efficacy of immunoradiotherapy

K. He, M. Cortez, Yun Hu, 2024, Journal of experimental & clinical cancer research : CR.

The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cells

J. Welsh, D. Bearss, L. Cooke, 2009, Radiation oncology.